Biogen Alzheimer’s drug moves to late stage trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for…
Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
LEQEMBI® (Lecanemab) Approved for the Treatment
TOKYO and CAMBRIDGE, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,…
Stock market today: Live updates
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S.,…